Diagnosis and treatment of cystic fibrosis. An update
- PMID: 6373170
- DOI: 10.1016/s0012-3692(16)62421-2
Diagnosis and treatment of cystic fibrosis. An update
Abstract
Cystic fibrosis is the most common fatal inherited disease of Caucasians. At present, cystic fibrosis accounts for most cases of chronic progressive pulmonary disease and for many other clinical features in the first three decades of life. Thus, it is a challenge to both pediatricians and internists, particularly chest physicians. The diagnosis is based on the triad of chronic obstructive pulmonary disease, pancreatic insufficiency, and increased levels of electrolytes in the sweat. The cardinal test for confirmation of the diagnosis is the "sweat test," which is an excellent discriminant for cystic fibrosis, even in adults. Ancillary features of cystic fibrosis may be of diagnostic assistance (eg, nasal polyposis, Pseudomonas aeruginosa in sputum, azoospermia, and others). Treatment of the pulmonary disease must be emphasized. Choice of antibiotics should be based on the results of sputum culture, but P aeruginosa is the most common pathogen. Removal of secretions by regular postural drainage and percussion is an integral part of the program. Pneumothorax, massive hemoptysis, cor pulmonale, and other complications may be encountered. Sinusitis is almost universal, and nasal polyposis is frequently present. Pancreatic insufficiency occurs in over 80 percent of the patients with cystic fibrosis and may result in intestinal malabsorption. Massive salt loss through the sweat in hot weather, a distinctive type of biliary cirrhosis without jaundice, gallbladder abnormalities, cholelithiasis, and diabetes mellitus also may be found. Of special importance are intestinal obstructive complications (meconium ileus in newborn infants with cystic fibrosis and intestinal obstruction due to fecal accumulation or intussusception in adults). Azoospermia is present in 95 percent of men and there is reduced fertility in women; however, pregnancy does occur in cystic fibrosis. This chronic and ultimately fatal disease produces a predictable set of psychosocial complications.
Similar articles
-
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 36990700 Chinese.
-
Low sweat electrolytes in a patient with cystic fibrosis.Am J Med. 1980 Oct;69(4):643-6. doi: 10.1016/0002-9343(80)90482-9. Am J Med. 1980. PMID: 7424954
-
ROENTGENOGRAPHIC SPECTRUM OF CYSTIC FIBROSIS.Postgrad Med. 1963 Sep;34:251-65. doi: 10.1080/00325481.1963.11694841. Postgrad Med. 1963. PMID: 14047300 No abstract available.
-
Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency).Presse Med. 2017 Jun;46(6 Pt 2):e109-e124. doi: 10.1016/j.lpm.2017.03.021. Epub 2017 May 26. Presse Med. 2017. PMID: 28554722 Review.
-
Surgical treatment and the patient with cystic fibrosis.Surg Gynecol Obstet. 1981 Jun;152(6):837-45. Surg Gynecol Obstet. 1981. PMID: 7017979 Review.
Cited by
-
Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients.Clin Exp Immunol. 1990 Jun;80(3):344-9. doi: 10.1111/j.1365-2249.1990.tb03290.x. Clin Exp Immunol. 1990. PMID: 2142640 Free PMC article.
-
Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.Clin Exp Immunol. 1992 Aug;89(2):321-4. doi: 10.1111/j.1365-2249.1992.tb06953.x. Clin Exp Immunol. 1992. PMID: 1322257 Free PMC article.
-
BTS guidelines for the management of spontaneous pneumothorax.Thorax. 2003 May;58 Suppl 2(Suppl 2):ii39-52. doi: 10.1136/thorax.58.suppl_2.ii39. Thorax. 2003. PMID: 12728149 Free PMC article. No abstract available.
-
Bronchial artery embolization for hemoptysis: A systematic review and meta-analysis.J Interv Med. 2021 Aug 13;4(4):172-180. doi: 10.1016/j.jimed.2021.08.003. eCollection 2021 Nov. J Interv Med. 2021. PMID: 35586385 Free PMC article.
-
Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.J Clin Microbiol. 1986 Aug;24(2):189-96. doi: 10.1128/jcm.24.2.189-196.1986. J Clin Microbiol. 1986. PMID: 2943759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical